Press Release Source: InterMune, Inc.
InterMune Names Thomas R. Hodgson to Board of Directors
Monday February 3, 4:19 pm ET
BRISBANE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN - News) announced today that Thomas R. Hodgson, former president and chief operating officer of Abbott Laboratories, has been appointed to the Board of Directors.
ADVERTISEMENT
Mr. Hodgson brings nearly 30 years of management experience from the pharmaceutical industry, most recently from Abbott Laboratories, where he worked in general management roles with increasing responsibility for more than 20 years. He served as President of the Hospital Products Division from 1978 to 1983; Executive Vice President and President of the International Division from 1983 to 1990; and was appointed to the Board of Directors in 1985. He was elected President and Chief Operating Officer in 1990 and continued in that role until his retirement in 1999.
"Thomas Hodgson is an outstanding addition to InterMune's Board of Directors, bringing a world-class pharmaceutical perspective and long history of operational success at the management and Board of Director levels to our company," said Scott Harkonen, President and Chief Executive Officer of InterMune. "We look forward to working with him as we implement InterMune's strategic goals on the commercial, clinical development and applied research fronts."
Prior to joining Abbott in 1972, Mr. Hodgson was an associate with Booz Allen and Hamilton Management Consultants. He is a trustee of Rush-Presbyterian-St. Luke's Medical Center, and is a member of the Board of Directors of The St. Paul Companies, Inc.; Idenix Pharmaceuticals; MacLean-Fogg Company and ARUP Laboratories.
Mr. Hodgson earned his bachelor's degree in chemical engineering from Purdue University, a master's degree in chemical engineering from the University of Michigan and a master's degree in business administration from Harvard University. He was awarded an honorary doctorate degree in engineering by Purdue University. |
